RARE ALERT: Motif Bio said to have kicked off $3 million equity fundraising - sources

Motif Bio, a clinic stage biopharmaceutical company, is tapping investors for up to $3 million.

People claiming to be familiar with the situation said Motif Bio is looking to raise the fresh capital at a 25pc discount to last Friday's opening price.

The proceeds from the equtiy fundraising will be used as working capital, said people claiming to be familiar with the matter...